Abstract
Pulmonary embolism is understood as occlusion of the pulmonary arterial bed by blood clots. This is a common pathology, but it is difficult to judge the true frequency of this disease. This is primarily due to the asymptomatic course of the disease when the segmental pulmonary arteries are affected, the second reason is undiagnosed cases of pulmonary embolism even with its massive nature (in 40-70% of patients) or an erroneous interpretation of clinical manifestations and the resulting diagnosis of another pathology. In terms of mortality, pulmonary embolism ranks 3rd among the causes of sudden death after myocardial infarction and stroke.
Publisher
PANORAMA Publishing House
Reference13 articles.
1. 1. Prevalence of risk factors for venous thrombosis in surgical patients with a history of thrombotic episodes / I. A. Sanets, V. V. Anichkin, N. I. Shevchenko [et al.]. Problems of health and ecology. 2015; 1 (43): 21-26.
2. 2. Masola B, Zaza G, OnistoM, Lupo A, Gambaro G. Glycosaminoglycans, proteoglycans and sulodexide and endothelium: biological role and pharmacological effects. Int Angiol 2014; 33: 243-54.
3. 3. Cox S., Eslick R., McLintock S. Efficacy and safety of thromboprophylaxis with enoxaparin for the prevention of venous thromboembolism associated with pregnancy. J Thrombocytopenia. 2019; 17: 1160-1170.
4. Dysfunction of endothelial cells and glycocalyx - viscous circle;Zhang;Matrix Biol,2018
5. 5. Gillett J. L. Treatment of superficial vein thrombosis of the lower extremities: update and current recommendations. Phlebolymphology. 2015; 22, 2: 82-88.